The Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has disclosed its position in Mural Oncology plc under Rule 8.3 of the Irish Takeover Panel Act, 1997. The disclosure involves the opening position as of June 2, 2025. Vanguard reveals an interest in $0.01 ordinary shares of Mural Oncology, holding 772,931 shares, which translates to a 4.48% shareholding.

No other classes of securities or parties are reported in this disclosure. Vanguard's interest includes no cash-settled or stock-settled derivatives. Additionally, the group purchased an additional 64 shares at 2.63 USD each. No indemnities, agreements, or other arrangements related to these securities are in place.